A novel tamanavirus (Flaviviridae) of the European common frog (Rana temporaria) from the UK
Journal of General Virology · 2023
DOI: 10.1099/jgv.0.001927 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of General Virology, 2023. Verfasst von Rhys H Parry und 6 weiteren Autor:innen. Beteiligte Einrichtung: School of Chemistry and Molecular Biosciences, The University of Queensland, Brisbane, QLD, Australia. Hauptthemen laut MEDLINE: Flaviviridae, Flavivirus. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 76 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Australian Research Council, National Health and Medical Research Council.
Abstract (Originalsprache)
Flavivirids are small, enveloped, positive-sense RNA viruses from the family Flaviviridae with genomes of ~9–13 kb. Metatranscriptomic analyses of metazoan organisms have revealed a diversity of flavivirus-like or flavivirid viral sequences in fish and marine invertebrate groups. However, no flavivirus-like virus has been identified in amphibians. To remedy this, we investigated the virome of the European common frog ( Rana temporaria ) in the UK, utilizing high-throughput sequencing at six catch locations. De novo assembly revealed a coding-complete virus contig of a novel flavivirid ~11.2 kb in length. The virus encodes a single ORF of 3456 aa and 5′ and 3′ untranslated regions (UTRs) of 227 and 666 nt, respectively. We named this virus Rana tamanavirus (RaTV), as BLASTp analysis of the polyprotein showed the closest relationships to Tamana bat virus (TABV) and Cyclopterus lumpus virus from Pteronotus parnellii and Cyclopterus lumpus , respectively. Phylogenetic analysis of the RaTV polyprotein compared to Flavivirus and Flavivirus-like members indicated that RaTV was sufficiently divergent and basal to the vertebrate Tamanavirus clade. In addition to the Mitcham strain, partial but divergent RaTV, sharing 95.64–97.39 % pairwise nucleotide identity, were also obtained from the Poole and Deal samples, indicating that RaTV is widespread in UK frog samples. Bioinformatic analyses of predicted secondary structures in the 3′UTR of RaTV showed the presence of an exoribonuclease-resistant RNA (xrRNA) structure standard in flaviviruses and TABV. To examine this biochemically, we conducted an in vitro Xrn1 digestion assay showing that RaTV probably forms a functional Xrn1-resistant xrRNA.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Chemistry and Molecular Biosciences, The University of Queensland, Brisbane, QLD, Australia.
- Australian Infectious Diseases Research Centre (AIDRC), Brisbane, QLD, Australia.
- Department of Pathobiological Sciences, University of Wisconsin-Madison, Madison, WI, USA.
- Institute of Zoology, Zoological Society of London, London, UK.
- Environment and Sustainability Institute, University of Exeter, Penryn, UK.
- Instituto de Patología Vegetal, Centro de Investigaciones Agropecuarias, Instituto Nacional de Tecnología Agropecuaria (IPAVE-CIAP-INTA), Córdoba X5020ICA, Argentina.
Förderung
- Australian Research Council
- National Health and Medical Research Council
Zitieren
APA
Parry, R. H., Slonchak, A., Campbell, L. J., Newton, N. D., Debat, H. J., Gifford, R. J., & Khromykh, A. A. (2023). A novel tamanavirus (Flaviviridae) of the European common frog (Rana temporaria) from the UK. Journal of General Virology. https://doi.org/10.1099/jgv.0.001927
Vancouver
Parry RH, Slonchak A, Campbell LJ, Newton ND, Debat HJ, Gifford RJ, et al. A novel tamanavirus (Flaviviridae) of the European common frog (Rana temporaria) from the UK. Journal of General Virology. 2023. doi:10.1099/jgv.0.001927
BibTeX
@article{Parry2023,
author = {Parry, Rhys H and Slonchak, Andrii and Campbell, Lewis J and Newton, Natalee D and Debat, Humberto J and Gifford, Robert J and Khromykh, Alexander A},
title = {A novel tamanavirus (Flaviviridae) of the European common frog (Rana temporaria) from the UK},
journal = {Journal of General Virology},
year = {2023},
doi = {10.1099/jgv.0.001927}
}
EUVIMED